Causes and consequences of aneuploidy in cancer - PubMed (original) (raw)

Review

. 2012 Jan 24;13(3):189-203.

doi: 10.1038/nrg3123.

Affiliations

• PMID: 22269907
• DOI: 10.1038/nrg3123

Review

Causes and consequences of aneuploidy in cancer

David J Gordon et al. Nat Rev Genet. 2012.

Abstract

Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer. Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood. Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations. We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.

PubMed Disclaimer

Similar articles

• Context is everything: aneuploidy in cancer.
  Ben-David U, Amon A. Ben-David U, et al. Nat Rev Genet. 2020 Jan;21(1):44-62. doi: 10.1038/s41576-019-0171-x. Epub 2019 Sep 23. Nat Rev Genet. 2020. PMID: 31548659 Review.
• CINister thoughts.
  Foijer F. Foijer F. Biochem Soc Trans. 2010 Dec;38(6):1715-21. doi: 10.1042/BST0381715. Biochem Soc Trans. 2010. PMID: 21118153 Review.
• Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis.
  Holland AJ, Cleveland DW. Holland AJ, et al. Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87. doi: 10.1038/nrm2718. Nat Rev Mol Cell Biol. 2009. PMID: 19546858 Free PMC article. Review.
• Single-chromosome Gains Commonly Function as Tumor Suppressors.
  Sheltzer JM, Ko JH, Replogle JM, Habibe Burgos NC, Chung ES, Meehl CM, Sayles NM, Passerini V, Storchova Z, Amon A. Sheltzer JM, et al. Cancer Cell. 2017 Feb 13;31(2):240-255. doi: 10.1016/j.ccell.2016.12.004. Epub 2017 Jan 12. Cancer Cell. 2017. PMID: 28089890 Free PMC article.
• Targeting chromosomal instability and aneuploidy in cancer.
  Bhatia S, Khanna KK, Duijf PHG. Bhatia S, et al. Trends Pharmacol Sci. 2024 Mar;45(3):210-224. doi: 10.1016/j.tips.2024.01.009. Epub 2024 Feb 13. Trends Pharmacol Sci. 2024. PMID: 38355324 Review.

Cited by

• Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker.
  Yang Y, Liu Q, Guo X, Yuan Q, Nian S, Kang P, Xu Z, Li L, Ye Y. Yang Y, et al. J Oncol. 2022 Aug 31;2022:8115474. doi: 10.1155/2022/8115474. eCollection 2022. J Oncol. 2022. PMID: 36090896 Free PMC article.
• Proteogenomic characterization of skull-base chordoma.
  Zhang Q, Xu Z, Han R, Wang Y, Ye Z, Zhu J, Cai Y, Zhang F, Zhao J, Yao B, Qin Z, Qiao N, Huang R, Feng J, Wang Y, Rui W, He F, Zhao Y, Ding C. Zhang Q, et al. Nat Commun. 2024 Sep 27;15(1):8338. doi: 10.1038/s41467-024-52285-7. Nat Commun. 2024. PMID: 39333076 Free PMC article.
• Roles and mechanisms of cellular senescence in regulation of tissue homeostasis.
  Ohtani N, Hara E. Ohtani N, et al. Cancer Sci. 2013 May;104(5):525-30. doi: 10.1111/cas.12118. Epub 2013 Mar 11. Cancer Sci. 2013. PMID: 23360516 Free PMC article. Review.
• Common Fragile Sites Are Characterized by Faulty Condensin Loading after Replication Stress.
  Boteva L, Nozawa RS, Naughton C, Samejima K, Earnshaw WC, Gilbert N. Boteva L, et al. Cell Rep. 2020 Sep 22;32(12):108177. doi: 10.1016/j.celrep.2020.108177. Cell Rep. 2020. PMID: 32966795 Free PMC article.

References

1. 1. Genes Dev. 2008 Aug 15;22(16):2189-203 - PubMed
2. 1. Cell Cycle. 2006 Mar;5(6):592-5 - PubMed
3. 1. Nat Genet. 1998 Sep;20(1):66-9 - PubMed
4. 1. J Histochem Cytochem. 2005 Mar;53(3):385-90 - PubMed
5. 1. J Cell Biol. 1982 Sep;94(3):549-56 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database